It should be recalled that increased proliferative activity is essentially mediated in tumour cells by pathways involving tyrosine kinase receptors, including the PI3K/AKT pathway, and so it appears that tumour cells activate mechanisms that not only increase their rate of proliferation but also provide the metabolic requirements for this to take place successfully. This evidence concerns the gene NTRK1 and neoplasm.